Literature DB >> 19057739

Canadian Association of General Surgeons and American College of Surgeons Evidence-Based Reviews in Surgery. 27. Quality-of-life outcomes with sentinel node biopsy versus standard axillary treatment in patients with operable breast cancer. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Steve Latosinsky1, Kelly Dabbs, Frederick Moffat.   

Abstract

Entities:  

Year:  2008        PMID： 19057739      PMCID： PMC2592588     

Source DB:  PubMed          Journal:  Can J Surg        ISSN： 0008-428X            Impact factor:   2.089


× No keyword cloud information.
  3 in total

1.  Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer.

Authors:  Seth P Harlow; David N Krag; Thomas B Julian; Takamaru Ashikaga; Donald L Weaver; Sheldon A Feldman; V Suzanne Klimberg; Roberto Kusminsky; Frederick L Moffat; R Dirk Noyes; Peter D Beitsch
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

Review 2.  Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile.

Authors:  V Duric; M Stockler
Journal:  Lancet Oncol       Date:  2001-11       Impact factor: 41.316

3.  Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.

Authors:  Anne Fleissig; Lesley J Fallowfield; Carolyn I Langridge; Leigh Johnson; Robert G Newcombe; J Michael Dixon; Mark Kissin; Robert E Mansel
Journal:  Breast Cancer Res Treat       Date:  2005-09-15       Impact factor: 4.872
  3 in total
  4 in total

1.  Prediction of axillary lymph node metastasis in triple-negative breast cancer by multi-omics analysis and an integrated model.

Authors:  Si-Yuan Li; Yu-Wei Li; Ding Ma; Zhi-Ming Shao
Journal:  Ann Transl Med       Date:  2022-06

2.  A Comparative Validation of Primary Surgical Versus Post-neo-adjuvant Chemotherapy Sentinel Lymph Node Biopsy for Stage III Breast Cancers.

Authors:  Gaurav Agarwal; Sendhil Rajan; Sanjay Gambhir; Punita Lal; Narendra Krishnani; Subhash Kheruka
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

Review 3.  Detection of Sentinel Lymph Nodes with Near-Infrared Imaging in Malignancies.

Authors:  Huan-Cheng Zeng; Jia-Lin Hu; Jing-Wen Bai; Guo-Jun Zhang
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

4.  Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Sarun Thongvitokomarn; Nuanphan Polchai
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.